Verinata’s Big Day Arrives, With Prenatal Down Syndrome Test Debut
Researchers have been dreaming for a couple decades of taking a simple blood draw from a pregnant woman, and using it to determine whether a developing fetus has Down syndrome. Now this week, after a decade of R&D fits and starts and $100 million of investment, doctors will be able to get their hands on a commercially available genomic test from Redwood City, CA-based Verinata Health that promises to deliver that answer.
The company, formerly known as Living Microsystems and Artemis Health, is poised to make that transition to the marketplace tomorrow with the rollout its Verifi prenatal genomic test. This test, developed with technology from Steve Quake’s lab at Stanford University, is the newest entrant in a market ... read more here>>>>>